Century-old Vaccine Protects Type 1 Diabetics from Infectious Diseases
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
Endocrinology
Contact Information
The Diabetes Unit at Mass General is recognized for its longstanding excellence in diabetes research and its significant contributions to the advancement of effective treatments. Noteworthy developments include the creation of the Bionic Pancreas (in partnership with Boston University), implantable insulin pumps, and innovative techniques for assessing long-term glucose control. Additionally, the GLP-1 was first tested in human subjects at the MGH Diabetes Research Center.
Researchers at Massachusetts General Hospital have led pivotal studies in disease and complication prevention, including the highly cited Diabetes Control and Complications Trial (DCCT) and the Diabetes Prevention Program. Ongoing research continues to build upon foundational work in the Diabetes Research Center, focusing on evidence generation across all types of diabetes, atypical presentations, diverse populations, epidemiology, genetics, precision medicine, individuals who are pregnant or lactating, and complication prevention. The availability of dedicated research examination rooms and laboratory facilities enables efficient processing and shipment of biological samples, thereby expediting study workflows and results.
Our interdisciplinary team comprises physicians, bench scientists, epidemiologists, statisticians, dietitians, nurses, clinical research coordinators, research technicians, students, and research fellows. This collective expertise supports our mission to advance the diagnosis, prevention, and treatment of all forms of diabetes and their associated complications.
We maintain collaborative partnerships with academic and industry researchers worldwide. Current collaborations include the Mass General Brigham Center for Genomic Medicine, the Broad Institute, and the Boston Area Diabetes Endocrinology Research Centers (BADERC). For inquiries regarding future collaborations, please contact us.
Our researchers include epidemiologists, physicians, bench scientists, dietitians and nurses.
View recent publications from the Diabetes Clinical and Translational Research Center. Some full-text articles may require a subscription.
The Diabetes Research Center is actively conducting clinical trials in areas such as cystic fibrosis-related diabetes, gestational diabetes, tumor-associated hyperinsulinism (tHI), rare and atypical diabetes, type 1 and type 2 diabetes, and lifestyle interventions targeting disease prevention.
For details on ongoing trials, visit rally.massgeneralbrigham.org and for a summary of our trials, see below.
For information about the MGH Diabetes Center Repository, visit here.
Selected current, recent, and past trials are listed below.
U.S. News & World Report ranks Mass General Diabetes & Endocrinology among the best in the nation.
For nearly 30 years, the research and clinical management services at Mass General’s Diabetes Unit has revolutionized the treatment of diabetes.
Your support of the Diabetes Unit helps us provide the best possible care today and expand what will be possible tomorrow.
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
Researchers have identified numerous genetic clusters that may help explain why people with type 2 diabetes have different clinical presentations.
In this 12-month, placebo-controlled, randomized clinical trial of 26 well-treated persons with HIV without known CVD, eplerenone was associated with a significant reduction in arterial inflammation.
Blocking reductive stress in the liver may benefit people with conditions such as obesity and fatty liver disease.
Florez now oversees the largest clinical and research department at Mass General, with 10 clinical divisions, seven research centers/units, and 19 training programs comprising over 1,000 faculty members, 900 trainees and 100 medical practices.